Key result
A sensitive and rapid LC-MS/MS method was successfully developed and applied for the simultaneous quantification and therapeutic drug monitoring of aspirin and clopidogrel in 67 patients with CAD.
A novel LC-MS/MS method allows for simultaneous therapeutic drug monitoring of aspirin, clopidogrel, and their metabolites in patients with coronary artery disease.
The interest in therapeutic drug monitoring has increased over the last few years. Inter- and intra-patient variability in pharmacokinetics, plasma concentration related toxicity and success of therapy have stressed the need of frequent therapeutic drug monitoring of the drugs. A sensitive, selective and rapid liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) method was developed for the simultaneous quantification of acetylsalicylic acid (aspirin), salicylic acid, clopidogrel and carboxylic acid metabolite of clopidogrel in human plasma. The chromatographic separations were achieved on Waters Symmetry Shield(TM) C18 column (150 × 4.6 mm, 5 µm) using 3.5 mm ammonium acetate (pH 3.5)-acetonitrile (10:90, v/v) as mobile phase at a flow rate of 0.75 mL/min. The present method was successfully applied for therapeutic drug monitoring of aspirin and clopidogrel in 67 patients with coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Chhonker et al. (2015) studied Coronary artery disease (n=67). LC-MS/MS method for simultaneous quantification of aspirin and clopidogrel was evaluated on Simultaneous quantification of acetylsalicylic acid, salicylic acid, clopidogrel and carboxylic acid metabolite of clopidogrel in human plasma. A sensitive and rapid LC-MS/MS method was successfully developed and applied for the simultaneous quantification and therapeutic drug monitoring of aspirin and clopidogrel in 67 patients with CAD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: